Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $136.73
Change -$3.05 | -2.18%
As Of 2/5/16

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.

Net Asset Value

Net Asset Value $136.73
Change -$3.05 | -2.18%


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


Volume 22,498
Last Sale Price $136.75
52-Week Range $164.72 / $136.73
Shares Outstanding 3,400,000
Total Net Assets $464,889,289.70

Market Close

Market Price $136.75
Premium / Discount $0.02
Change -$3.02 | -2.16%
High / Low $139.72 / $136.13

Historical Market Closes to NAV

  Days % of Total Days
Premium 1207 51.80%
Discount 1000 42.92%
Equal to NAV 123 5.28%
Total 2,330 100%


Number of Stocks 56
Return on Equity (quarterly 12/31/15) 14.83%
Price to Earning (P/E) 23.80
Price to Book (P/B) 3.44
Dividend Amount $0.21
Ex-Dividend Date N/A


As of 1/29/16
Standard Deviation Sharpe Ratio Beta R-Squared
12.82 1.47 1.00 99.86


Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.
Return on Equity Measures a company’s profitability by demonstrating how much profit a company generates with money invested by shareholders. It is calculated by dividing a company’s 12 month net income by shareholder equity and is expressed as a percentage.
Price to Earns (P/E) The weighted average of each individual stock’s P/E ratio. The P/E ratio of a stock is calculated by dividing the current price of the stock by its trailing 12 month’s earnings per share.
Price to Book (P/B) The market price of a stock divided by the book value per share.


as of 2/5/2016
Total Assets $464,889,290
Number of Stocks 56
Percent Stock 99.89%
Percent Cash / Other 0.11%

Sectors / Industries

as of 2/5/16


as of 2/5/16

Security Name Ticker Shares
% of Net Assets Sector / Industry
STRYKER CORP SYK 97,857 $9,483,321.87 2.04% Health Care Equipment & Supplies
HCA HOLDINGS INC HCA 136,086 $9,415,790.34 2.03% Health Care Providers & Services
EDWARDS LIFESCIENCES CORP EW 112,989 $9,267,357.78 1.99% Health Care Equipment & Supplies
BAXALTA INC BXLT 243,595 $9,251,738.10 1.99% Biotechnology
INTUITIVE SURGICAL, INC. ISRG 17,230 $9,239,415.20 1.99% Health Care Equipment & Supplies
BAXTER INTERNATIONAL BAX 244,916 $9,181,900.84 1.98% Health Care Equipment & Supplies
MALLINCKRODT PLC MNK 130,066 $9,036,985.68 1.94% Pharmaceuticals
C.R. BARD, INC. BCR 49,320 $9,021,121.20 1.94% Health Care Equipment & Supplies
JOHNSON & JOHNSON JNJ 88,737 $8,921,617.98 1.92% Pharmaceuticals
DENTSPLY INTERNATIONAL XRAY 150,906 $8,901,944.94 1.91% Health Care Equipment & Supplies
ABBVIE INC ABBV 166,963 $8,869,074.56 1.91% Biotechnology
MYLAN NV MYL 171,665 $8,821,864.35 1.90% Pharmaceuticals
PERRIGO COMPANY PRGO 61,294 $8,818,980.72 1.90% Pharmaceuticals
PATTERSON COS INC PDCO 206,185 $8,787,604.70 1.89% Health Care Providers & Services
MEDTRONIC PLC MDT 117,711 $8,764,761.06 1.89% Health Care Equipment & Supplies
HENRY SCHEIN, INC. HSIC 58,904 $8,710,134.48 1.87% Health Care Providers & Services
UNITEDHEALTH GROUP INC. UNH 77,797 $8,691,480.84 1.87% Health Care Providers & Services
VARIAN MEDICAL SYSTEMS IN VAR 116,183 $8,677,708.27 1.87% Health Care Equipment & Supplies
ZIMMER BIOMET HOLDINGS INC ZBH 91,177 $8,662,726.77 1.86% Health Care Equipment & Supplies
HUMANA, INC. HUM 52,221 $8,604,976.38 1.85% Health Care Providers & Services
CIGNA CORPORATION CI 64,413 $8,570,149.65 1.84% Health Care Providers & Services
MERCK & COMPANY, INC. MRK 173,013 $8,543,381.94 1.84% Pharmaceuticals
AETNA INC AET 86,002 $8,533,118.44 1.84% Health Care Providers & Services
ENDO INETERNATIONAL PLC ENDP 157,962 $8,509,412.94 1.83% Pharmaceuticals
AMGEN INC. AMGN 58,155 $8,434,801.20 1.81% Biotechnology
BIOGEN IDEC, INC. BIIB 31,829 $8,398,399.94 1.81% Biotechnology
CERNER CORPORATION CERN 150,380 $8,317,517.80 1.79% Health Care Technology
QUEST DIAGNOSTICS, INC. DGX 133,708 $8,296,581.40 1.78% Health Care Providers & Services
BOSTON SCIENTIFIC CORP BSX 498,500 $8,285,070.00 1.78% Health Care Equipment & Supplies
THERMO FISHER SCIENTIFIC TMO 67,234 $8,281,884.12 1.78% Life Sciences Tools & Services
DAVITA, INC DVA 129,432 $8,270,704.80 1.78% Health Care Providers & Services
UNIVERSAL HEALTH SERVICES UHS 75,506 $8,233,174.24 1.77% Health Care Providers & Services
ANTHEM INC. ANTM 66,448 $8,198,354.24 1.76% Health Care Providers & Services
ALLERGAN PLC AGN 29,868 $8,177,858.40 1.76% Pharmaceuticals
PFIZER INC PFE 281,435 $8,170,058.05 1.76% Pharmaceuticals
CELGENE CORPORATION CELG 83,261 $8,150,419.29 1.75% Biotechnology
AGILENT TECHNOLOGIES, INC A 224,502 $8,091,052.08 1.74% Life Sciences Tools & Services
ZOETIS INC ZTS 196,874 $8,054,115.34 1.73% Pharmaceuticals
ELI LILLY & COMPANY LLY 108,329 $8,051,011.28 1.73% Pharmaceuticals
CARDINAL HEALTH, INC. CAH 105,035 $8,046,731.35 1.73% Health Care Providers & Services
WATERS CORPORATION WAT 69,679 $8,045,834.13 1.73% Life Sciences Tools & Services
BECTON DICKINSON & CO BDX 59,483 $8,045,075.75 1.73% Health Care Equipment & Supplies
BRISTOL MYERS SQUIBB CO BMY 133,433 $7,956,609.79 1.71% Pharmaceuticals
LABORATORY CORP OF AMERIC LH 74,463 $7,905,736.71 1.70% Health Care Providers & Services
TENET HEALTHCARE CORP THC 300,759 $7,792,665.69 1.68% Health Care Providers & Services
PERKINELMER PKI 179,451 $7,763,050.26 1.67% Life Sciences Tools & Services
GILEAD SCIENCES, INC. GILD 90,200 $7,679,628.00 1.65% Biotechnology
ST. JUDE MEDICAL INC. STJ 148,814 $7,620,764.94 1.64% Health Care Equipment & Supplies
ABBOTT LABORATORIES ABT 203,397 $7,609,081.77 1.64% Health Care Equipment & Supplies
AMERISOURCEBERGEN CORP ABC 88,389 $7,486,548.30 1.61% Health Care Providers & Services
MCKESSON CORPORATION MCK 47,431 $7,321,449.16 1.57% Health Care Providers & Services
EXPRESS SCRIPTS HLDGS ESRX 106,153 $7,201,419.52 1.55% Health Care Providers & Services
ILLUMINA INC ILMN 51,612 $7,021,812.60 1.51% Life Sciences Tools & Services
ALEXION PHARMACEUTICALS I ALXN 47,972 $6,825,456.16 1.47% Biotechnology
REGENERON PHARMACEUTICALS REGN 16,879 $6,694,380.19 1.44% Biotechnology
VERTEX PHARMACEUTICALS VRTX 76,700 $6,642,987.00 1.43% Biotechnology


*Morningstar category is based on the underlying securities of the ETF and not the objective. The Morningstar Rating™ is provided for those exchange-traded funds ("ETFs") with at least a three-year history. Ratings are based on the ETF’s Morningstar Risk-Adjusted Return measure which accounts for variation in monthly performance, placing more emphasis on downward variations and rewarding consistent performance. An ETF’s risk-adjusted return includes a brokerage commission estimate. This estimate is intended to reflect what an average investor would pay when buying or selling an ETF. PLEASE NOTE, this estimate is subject to change and the actual brokerage commission an investor pays may be higher or lower than this estimate. Morningstar compares each ETF’s risk-adjusted return to the open-end mutual fund rating breakpoints for that category. Consistent with the open-end mutual fund ratings, the top 10% of ETFs in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. The overall rating for an ETF is based on a weighted average of the timeperiod ratings (e.g., the ETF’s 3-, 5-, and 10-year rating). The determination of an ETF’s rating does not affect the retail open end mutual fund data published by Morningstar. Past performance is no guarantee of future results.

Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

Standard & Poor's® and S&P® are registered trademarks of Standard & Poor's Financial Services LLC, a subsidiary of McGraw Hill Financial, Inc., and have been licensed for use by Guggenheim Investments and its affiliates. Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC. S&P Dow Jones Indices LLC (together with its affiliates, "S&P") does not make investment recommendations, and S&P does not sponsor, endorse, sell or promote the product. S&P makes no representation or warranty regarding the advisability of investing in the product. Past performance of an index is not a guarantee of future results.

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.


Subscribe to Perspectives

©2016 Guggenheim Investments. All Rights Reserved.

• Not FDIC Insured • No Bank Guarantee • May Lose Value